Quaglino D, Di Leonardo G, Lalli G, Pasqualoni E, Di Simone S, Vecchio L, Ventura T
Clinica Medica II, Università degli Studi de L'Aquila, Italy.
Eur Rev Med Pharmacol Sci. 1997 Jan-Jun;1(1-3):11-6.
The authors describe a case of cutaneous neuroendocrine (Merkell cell) carcinoma in a patient previously treated for Chronic Lymphocytic Leukaemia (CLL). The authors discuss some of the mechanisms concerning the increased frequency of a second tumour in patients with CLL and focus attention on the high incidence in CLL of secondary tumours, especially skin tumours, of which Merkell cell carcinoma is a rare example. The authors consider the possible therapeutic approaches, reported in the literature, for the treatment of this particular skin carcinoma, which on account of its aggressiveness and the preexistence of a leukaemic process requires a particularly careful therapeutic approach.
作者描述了一例曾接受慢性淋巴细胞白血病(CLL)治疗的患者发生皮肤神经内分泌(默克尔细胞)癌的病例。作者讨论了一些关于CLL患者继发性肿瘤发生率增加的机制,并将注意力集中在CLL患者继发性肿瘤的高发病率上,尤其是皮肤肿瘤,其中默克尔细胞癌是一个罕见的例子。作者考虑了文献中报道的针对这种特殊皮肤癌的可能治疗方法,鉴于其侵袭性和白血病病程的先前存在,这种皮肤癌需要特别谨慎的治疗方法。